Venus Remedies, a research-based global pharmaceutical company, is all set to stamp its footprint in Southeast Asia with marketing authorisation for its flagship research product, Elores, from Myanmar. The company plans to launch the drug in Myanmar by April.
Pawan Chaudhary, Chairman and Managing Director, Venus Remedies said, “This marketing authorisation will help us make big strides in Southeast Asia. The size of Myanmar’s pharmaceutical market is $400 million and the country imports 85-90 per cent of its pharma products. We are looking to capture a sizeable chunk of the antibiotics market in Myanmar with Elores. A few months ago, we had got marketing approval for Elores from Guatemala. It is rewarding to see our research products gaining international recognition.”
Venus Remedies has already received patents for Elores from 46 countries. The registration procedure of this product is in advanced stages in 13 European Union member-nations and 15 other countries, including South Korea, South Africa and Saudi Arabia. The company has signed deals with South Korean pharmaceutical company Goodwill Pharma and South African firm Austell Laboratories for the exclusive marketing of Elores.
EP News Bureau– Mumbai
- Advertisement -
